Editas Medicine, Inc. (EDIT)

$3.76 -3.84% $-0.15 Healthcare

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumor cancers; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has an early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

$310.11M

Dr. Gilmore O'Neill

264.00

Cambridge, MA

Feb 03, 2016

-1.61

$-2.33

0.87

3.85

-288.59%

-1.66

-0.06

1.39

4.81

3.85

-50.27%

-62.61%

Similar stocks (9)

Vertex Pharmaceuticals Incorporated

VRTX

$466.85 -2.31%
Neutral

Intellia Therapeutics, Inc.

NTLA

$22.16 -3.36%
Downtrend

Beam Therapeutics Inc.

BEAM

$25.62 -1.61%
Downtrend

Sana Biotechnology, Inc.

SANA

$4.28 -7.46%
Downtrend

Allogene Therapeutics, Inc.

ALLO

$2.85 -2.06%
Downtrend

Prime Medicine, Inc.

PRME

$3.80 -2.81%
Downtrend

Verve Therapeutics, Inc.

VERV

$5.24 -2.60%
Downtrend

Ginkgo Bioworks Holdings, Inc.

DNA

$7.82 -5.90%
Downtrend

Caribou Biosciences, Inc.

CRBU

$2.07 0.00%
Downtrend

ETF Exposure (50)

Listed Funds Trust - Horizon Kinetics Medical ETF

MEDX

0.6%

$31.40 0.14%
Uptrend

Robo Global Healthcare Technology and Innovation ETF

HTEC

0.59%

$29.27 -1.38%
Uptrend

Global X Genomics & Biotechnology ETF

GNOM

0.5%

$11.34 -1.90%
Uptrend

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.358%

$27.63 0.44%
Uptrend

iShares Genomics Immunology and Healthcare ETF

IDNA

0.32153%

$24.86 -1.03%
Uptrend

Etho Climate Leadership U.S. ETF

ETHO

0.17%

$59.78 -0.76%
Uptrend

Vanguard Strategic Small-Cap Equity Fund Investor Shares

VSTCX

0.12%

$42.94 2.14%
Uptrend

SPDR S&P Biotech ETF

XBI

0.113392%

$101.43 -0.98%
Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.0734569301%

$139.61 -3.02%
Uptrend

Vanguard Horizon Funds - Vanguard Strategic Equity Fund

VSEQX

0.07%

$39.87 1.84%
Uptrend

SPDR S&P Kensho New Economies Composite ETF

KOMP

0.065525%

$48.13 -0.72%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.03%

$24.36 -1.22%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.03%

$149.04 -0.85%
Uptrend

iShares Biotechnology ETF

IBB

0.02727%

$147.75 -1.15%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.02247%

$168.50 -1.11%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.02%

$89.74 -0.93%
Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

0.018527039999999998%

$55.32 -1.06%
Uptrend

iShares Russell 2000 ETF

IWM

0.0114%

$221.92 -0.91%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0113248127%

$51.55 -0.79%
Uptrend

Vanguard Small Cap Growth Index Fund

VBK

0.01%

$265.79 -0.61%
Uptrend

Vanguard Health Care Index Fund

VHT

0.01%

$284.88 -0.55%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0.01%

$138.77 2.02%
Uptrend

Vanguard Extended Market Index Fund

VXF

0.01%

$181.47 -0.79%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.008278998476982316%

$67.08 -1.69%
Uptrend

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.008%

$41.66 -0.94%
Uptrend

WisdomTree BioRevolution Fund

WDNA

0.006989%

$16.72 -1.21%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.00611423%

$64.50 -0.94%
Uptrend

SPDR Portfolio MSCI Global Stock Market ETF

SPGM

0.005918%

$63.62 -0.55%
Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.00492627%

$73.15 -0.48%
Uptrend

ProShares Ultra Russell2000

UWM

0.004284357278463713%

$43.23 -1.95%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0021118186994496294%

$52.68 -2.92%
Uptrend

ProShares Hedge Replication ETF

HDG

0.001791820906805638%

$50.11 0.08%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

8.588179e-4%

$65.90 -0.51%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

7.7e-4%

$124.61 -0.51%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

6.902e-4%

$39.17 -0.58%
Uptrend

Dimensional U.S. Equity ETF

DFUS

5.0561e-4%

$61.45 -0.49%
Uptrend

iShares Russell 3000 ETF

IWV

4.6e-4%

$324.19 -0.44%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$69.62 -0.85%
Uptrend

Vanguard Small Cap Index Fund

NAESX

0%

$113.87 1.75%
Uptrend

Vanguard Small Cap Index Fund

VB

0%

$235.97 -0.73%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Small-Cap Index Fund Institutional Shares

VSCIX

0%

$113.90 1.75%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$251.87 -0.47%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$280.66 -0.49%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend